Integrated Magnetic Systems Ltd
Small, uniform & low-cost all-biological magnetic nanoparticles that enable advanced applications in purification, diagnosis & therapeutics.
Integrated Magnetic Systems Ltd (IMSL) sells magnetic proteins - created by genetically fusing a targeting entity with a metal binding entity - for microscale bioseparations, while further developing the platform technology for diagnostic and therapeutic opportunities in medicine. It has raised more than £500K in contracts and grants, and £1M in equity investment since becoming operational in July 2011. It has a number of live B2B collaborations.